| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/12/1997 | EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces |
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
| 03/12/1997 | EP0761232A1 Antiallergic agent comprising anti-PAF receptor antibodies |
| 03/12/1997 | EP0761231A1 Vaccine composition containing adjuvants |
| 03/12/1997 | EP0761230A2 Vaccine containing Bordetella pertussis outer membrane protein, and method of making such vaccine |
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
| 03/12/1997 | EP0760859A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines |
| 03/12/1997 | EP0760857A1 Receptor for oncostatin m |
| 03/12/1997 | EP0760855A1 Hepatitis c virus asialoglycoproteins |
| 03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) |
| 03/12/1997 | EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760676A1 Materials and methods for treatment of plaquing diseases |
| 03/12/1997 | EP0760671A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0538283B1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 03/12/1997 | EP0489048B1 Inhibition of tumor growth by blockade of the protein c system |
| 03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
| 03/12/1997 | CN1144604A Anti-virus immunological milk |
| 03/11/1997 | US5610283 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
| 03/11/1997 | US5610280 Antitumor |
| 03/11/1997 | US5610276 Determination whether a cell is cancerous |
| 03/11/1997 | US5610057 Monoclonal antibody specific for IgA receptor |
| 03/11/1997 | US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus |
| 03/11/1997 | US5610049 Human rotavirus HCR3A and method of growing said rotavirus |
| 03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
| 03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
| 03/11/1997 | US5609876 Peptide vaccines and associated methods for protection against feline leukemia virus |
| 03/11/1997 | US5609872 Peptides comprising a protective epitope from blood stages of plasmodium falciparum |
| 03/11/1997 | US5609871 Microencapsulating enteric coating |
| 03/11/1997 | US5609870 Antisecretory, immunology |
| 03/11/1997 | US5609846 Cytokines, interleukins, reduced side effects |
| 03/06/1997 | WO1997008553A1 Targeting of proteins to the cell wall of gram-positive bacteria |
| 03/06/1997 | WO1997008328A1 Selective elimination of t cells that recognize specific preselected targets |
| 03/06/1997 | WO1997008324A1 Methods for enhancing the production of interferon in cell culture |
| 03/06/1997 | WO1997008322A1 Mpt83 gene from mycobacterium tuberculosis |
| 03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | WO1997008318A2 Compounds and methods for treatment and diagnosis of prostate cancer |
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 03/06/1997 | WO1997008296A1 Method of growing rickettsiae in ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae |
| 03/06/1997 | WO1997008292A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | WO1997007823A2 Compositions and their uses |
| 03/06/1997 | WO1997007818A1 Vaccines |
| 03/06/1997 | WO1997007817A1 Multi-subtype fiv vaccines |
| 03/06/1997 | WO1997007769A2 Chemical compounds |
| 03/06/1997 | WO1997007674A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | WO1996040929A3 Transferrin receptor genes |
| 03/06/1997 | WO1996036354A3 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 03/06/1997 | WO1994006911A3 Mycoplasma pulmonis antigens and methods and compositions for use in cloning and vaccination |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2625279A1 Chromatographic purification of adenovirus and aav |
| 03/06/1997 | CA2230671A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | CA2229860A1 Vaccines |
| 03/06/1997 | CA2229844A1 Compositions and their uses |
| 03/06/1997 | CA2227040A1 Chemical compounds |
| 03/05/1997 | EP0760394A1 Mild Newcastle disease virus vaccine |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759988A1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759976A1 The isolation and production of catalytic antibodies using phage technology |
| 03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759941A1 Heterodimer polypeptide immunogen carrier composition and method |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759936A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression |
| 03/05/1997 | EP0759935A1 Recombinant papilloma virus l1 |
| 03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 03/05/1997 | EP0759782A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 03/05/1997 | EP0759781A1 Method for treating and preventing atherosclerosis |
| 03/05/1997 | EP0759780A1 Improved modified live brsv vaccine |
| 03/05/1997 | EP0759779A1 Vaccines for oral immunization against infecting agents |
| 03/05/1997 | EP0759778A1 Non-infective vaccines |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | EP0759771A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0656064B1 Bispecific immunoadhesins |
| 03/05/1997 | EP0498804B1 A method of preparing a vaccine or toxoid |
| 03/05/1997 | CN1144536A Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 03/05/1997 | CN1144489A Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 03/05/1997 | CN1144272A Hepatitis B surface antigen containing front surface antigen 1 and 2 immunodeterminant |
| 03/04/1997 | US5608060 Diagnosis and treatment of cancer; drug delivery to target cells |
| 03/04/1997 | US5608038 Highly concentrated immunoglobulin preparation and method for its production |
| 03/04/1997 | US5607924 DNA photocleavage using texaphyrins |
| 03/04/1997 | US5607852 Process for attenuated varicella zoster virus vaccine production |
| 03/04/1997 | US5607851 Process for purifying hepatitis a virus (HAV), and vaccine compositions containing hepatitis a virus |
| 03/04/1997 | US5607847 Cells, monoclonal antibodies and hybridomas |
| 03/04/1997 | US5607846 Vaccine for moraxella catarrhalis |
| 03/04/1997 | US5607677 Glucan drug delivery system and adjuvant |
| 03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
| 03/04/1997 | CA2067797C Production and use of human nm23 protein and antibodies therefor |
| 03/04/1997 | CA1338957C Avirulent microbes and uses therefor |
| 02/27/1997 | WO1997007399A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |